Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 125
- 试验地点
- 2
- 主要终点
- Number of Patients Treatment Interruption
研究概览
简要总结
The purpose of this research is to understand how screening for patient resource needs followed by customized resource matching can improve outcomes for adults with breast, lung or gastrointestinal cancer.
详细描述
This research study is an intervention assessment; this is the first-time investigators are examining the impact of screening for resource needs followed by customized resource matching at Dana-Farber Cancer Institute.
-
The research study procedures include screening for social determinants of health (resource) needs and, depending on study group, resource matching.
-
Participants will be randomized into one of two groups.
-
Usual Care or Usual Care with customized resource matching.
It is expected that about 125 participants will take part in this research study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Eligible patients will be adults age 18 or older, able to consent, scheduled for a new patient consultation in DFCI BOC, TOP or GCC. To select for patients from demographic groups vulnerable to SDoH needs, two different groups will be eligible to participate.
- •BIPOC (Black, Latinx, Native American or Pacific Islander)
- •LEP Spanish-speaking (As indicated by the EHR)
- •Low SES (from zip code with median household income <$32,000/year) OR
- •Any one NPIQ response indicating SDoH need
- •Health literacy/numeracy, Caregiving/relationships, OR Finances
排除标准
- •Group A and B
- •- Patients not continuing care at Dana Farber Cancer Institute
结局指标
主要结局
Number of Patients Treatment Interruption
时间窗: 180 Days
Number of interruptions to cancer treatment (defined here as treatment hold, reduction, discontinuation or ED visits/hospitalizations as indicated by the patient medical record)
Rate of Treatment Interruption
时间窗: 180 Days
Rate of interruptions to cancer treatment (defined here as treatment hold, reduction, discontinuation or ED visits/hospitalizations as indicated by the patient medical record)
次要结局
未报告次要终点
研究者
Nadine McCleary, MD, MPH
Principal Investigator
Dana-Farber Cancer Institute